Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 07, 2015 16:04 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Reports First Quarter 2015 Financial Results and Provides Corporate Update

Reports PROCYSBI® Sales of $20.5 Million in First Quarter Company to Host Conference Call and Webcast Today at 4:30 p.m. ET/1:30 p.m. PT NOVATO, Calif., May 7, 2015 (GLOBE NEWSWIRE) --...
February 10, 2015 09:51 ET | Source: Raptor Pharmaceutical Inc

PROCYSBI(R) to Receive New Treatment Award From Lysosomal Disease Network at the 11th Annual WORLD Symposium

NOVATO, Calif., Feb. 10, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that the Lysosomal Disease Network (LDN) will present Raptor Pharmaceutical with the 2015...
November 06, 2014 16:05 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Reports Third Quarter 2014 Financial Results and Provides Corporate Update

Global Net Product Sales for PROCYSBI® of $23.8 Million for Third Quarter 2014 PROCYSBI Revenue of $52.2 Million Reached Through September 2014 PROCYSBI Revenue Guidance of $65-$70 Million...
September 23, 2014 08:00 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical to Present at Leerink Rare Disease Roundtable

NOVATO, Calif., Sept. 23, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that company management will present at the Leerink Rare Disease Roundtable in New York on...
August 07, 2014 16:05 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Reports Second Quarter 2014 Financial Results and Provides Corporate Update

Global net product sales for PROCYSBI® of $16.3 million reported for second quarter 2014 Raising net sales guidance for PROCYSBI to $65 to $70 million for 2014 Company to host...
August 06, 2014 16:09 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical to Present at Upcoming Investor Conference

NOVATO, Calif., Aug. 6, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that company management will present at the Canaccord Genuity Annual Growth Conference in...
July 28, 2014 16:05 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical to Hold Second Quarter 2014 Financial Results Webcast and Conference Call

NOVATO, Calif., July 28, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that it will release second quarter 2014 financial results after market close on Thursday,...
July 01, 2014 17:13 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Enters Into $70 Million Financing Transaction and Amended Loan Agreement With HealthCare Royalty Partners

NOVATO, Calif., July 1, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that it has entered into agreements for $70 million in funding from HealthCare Royalty...
June 24, 2014 07:00 ET | Source: Raptor Pharmaceutical Inc

Data Published in Journal of Pediatrics Demonstrated That PROCYSBI(R) Improved Quality of Life and Preserved Kidney Function in Cystinosis Patients

NOVATO, Calif., June 24, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that data from its open label extension study of delayed-release cysteamine bitartrate...
May 08, 2014 16:05 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Reports First Quarter 2014 Financial Results and Provides Corporate Update

Reports PROCYSBI® net product sales of $12.1 million in first quarter 2014 and launch of PROCYSBI® in Germany Company to host conference call and webcast today at 4:30 p.m. EDT...